University of California, Los Angeles About Us   |   Diversity and Inclusion  |   Contact Us   |   Campus Directory   |   Giving   |   Maps/Directions
Shaping the Future

Bhavik Shah, M.D.

Contact Information:

Work Phone Number:

(310) 206-8092
(310) 825-7773
(310)-825-6301

Mailing Address:

760 Westwood Plaza, 58-242C Semel Institute
Los Angeles, CA 90095
UNITED STATES

Email Address:

bshah@mednet.ucla.edu

Website:

  

Home Page:

     Web-Profile


Unit Chief for 5-West, Inpatient Child and Adolescent Service

Associate Clinical Professor, Psychiatry and Biobehavioral Sciences

Center for Autism Research and Treatment (CART)


A Short Biography:

Dr. Bhavik Shah is devoted to clinical services and treatment for children with developmental disabilities, genetic syndromes, Autism, and Asperger disorder. He is also the medical director of a very unique child partial hospital program (ABC Program) that is open to all children with behavioral difficulties and psychiatric disorders. This is a comprehensive program for children with various psychiatric or developmental disabilities that require diagnosis, treatment, and education. He is also in charge of the Autism Psychopharmacology Clinic and two contract based Regional Center clinics.

Awards and Honors:

UCLA Neuropsychiatric Hospital
UCLA Neuropsychiatric Hospital
UCLA Neuropsychiatric Hospital

Detailed Biography:

Bhavik Shah M.D. Autism Mental Retardation Genetic syndromes with behavioral issues Child partial hospital program (ABC Program)

Publications:

Nikolov Roumen N, Bearss Karen E, Lettinga Jelle, Erickson Craig, Rodowski Maria, Aman Michael G, McCracken James T, McDougle Christopher J, Tierney Elaine, Vitiello Benedetto, Arnold L Eugene, Shah Bhavik, Posey David J, Ritz Louise, Scahill Lawrence   Gastrointestinal symptoms in a sample of children with pervasive developmental disorders Journal of autism and developmental disorders, 2009; 39(3): 405-13.
Tierney Elaine, Aman Michael, Stout David, Pappas Krista, Arnold L Eugene, Vitiello Benedetto, Scahill Lawrence, McDougle Christopher, McCracken James, Wheeler Courtney, Martin Andres, Posey David, Shah Bhavik   Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study Psychopharmacology, 2007; 191(1): 149-57.
Anderson George M, Scahill Lawrence, McCracken James T, McDougle Christopher J, Aman Michael G, Tierney Elaine, Arnold L Eugene, Martin Andrés, Katsovich Liliya, Posey David J, Shah Bhavik, Vitiello Benedetto   Effects of short- and long-term risperidone treatment on prolactin levels in children with autism Biological psychiatry, 2007; 61(4): 545-50.
Posey David J, Aman Michael G, McCracken James T, Scahill Lawrence, Tierney Elaine, Arnold L Eugene, Vitiello Benedetto, Chuang Shirley Z, Davies Mark, Ramadan Yaser, Witwer Andrea N, Swiezy Naomi B, Cronin Pegeen, Shah Bhavik, Carroll Deirdre H, Young Christopher, Wheeler Courtney, McDougle Christopher J   Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures Biological psychiatry, 2007; 61(4): 538-44.
Scahill Lawrence, Aman Michael G, McDougle Christopher J, McCracken James T, Tierney Elaine, Dziura James, Arnold L Eugene, Posey David, Young Christopher, Shah Bhavik, Ghuman Jaswinder, Ritz Louise, Vitiello Benedetto   A prospective open trial of guanfacine in children with pervasive developmental disorders Journal of child and adolescent psychopharmacology, 2006; 16(5): 589-98.
Aman Michael G, Arnold L Eugene, McDougle Christopher J, Vitiello Benedetto, Scahill Lawrence, Davies Mark, McCracken James T, Tierney Elaine, Nash Patricia L, Posey David J, Chuang Shirley, Martin Andres, Shah Bhavik, Gonzalez Nilda M, Swiezy Naomi B, Ritz Louise, Koenig Kathleen, McGough James, Ghuman Jaswinder K, Lindsay Ronald L   Acute and long-term safety and tolerability of risperidone in children with autism Journal of child and adolescent psychopharmacology, 2005; 15(6): 869-84.
McDougle Christopher J, Scahill Lawrence, Aman Michael G, McCracken James T, Tierney Elaine, Davies Mark, Arnold L Eugene, Posey David J, Martin Andrès, Ghuman Jaswinder K, Shah Bhavik, Chuang Shirley Z, Swiezy Naomi B, Gonzalez Nilda M, Hollway Jill, Koenig Kathleen, McGough James J, Ritz Louise, Vitiello Benedetto   Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology The American journal of psychiatry, 2005; 162(6): 1142-8.
Arnold L Eugene, Vitiello Benedetto, McDougle Christopher, Scahill Larry, Shah Bhavik, Gonzalez Nilda M, Chuang Shirley, Davies Mark, Hollway Jill, Aman Michael G, Cronin Pegeen, Koenig Kathleen, Kohn Arlene E, McMahon Donald J, Tierney Elaine   Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials Journal of the American Academy of Child and Adolescent Psychiatry, 2003; 42(12): 1443-50.
Dykens Elisabeth, Shah Bhavik   Psychiatric disorders in Prader-Willi syndrome: epidemiology and management CNS drugs, 2003; 17(3): 167-78.
O'Connor Mary J, Shah Bhavik, Whaley Shannon, Cronin Pegeen, Gunderson Brent, Graham John   Psychiatric illness in a clinical sample of children with prenatal alcohol exposure The American journal of drug and alcohol abuse, 2002; 28(4): 743-54.
McCracken James T, McGough James, Shah Bhavik, Cronin Pegeen, Hong Daniel, Aman Michael G, Arnold L Eugene, Lindsay Ronald, Nash Patricia, Hollway Jill, McDougle Christopher J, Posey David, Swiezy Naomi, Kohn Arlene, Scahill Lawrence, Martin Andres, Koenig Kathleen, Volkmar Fred, Carroll Deirdre, Lancor Allison, Tierney Elaine, Ghuman Jaswinder, Gonzalez Nilda M, Grados Marco, Vitiello Benedetto, Ritz Louise, Davies Mark, Robinson James, McMahon Don, McMahon Don   Risperidone in children with autism and serious behavioral problems The New England journal of medicine, 2002; 347(5): 314-21.
UCLA    |    Abuse-Free Environment    |    Terms & Conditions    |    Disability Resources    |    UC Regents